Click any moment to jump to that point in the video
Dr. Palmer explains the historical context of metabolic psychiatry, highlighting how researchers in the late 1800s to mid-1900s focused on metabolism's role in mental illness before the field shifted towards neurotransmitters and psychosocial factors. He emphasizes the importance of unifying biological, psychological, and social aspects for a more comprehensive understanding of mental health.
Dr. Palmer challenges the reductionist view of depression as solely a neurotransmitter deficiency. He introduces metabolism and mitochondrial function as umbrella concepts encompassing neurotransmitter production, regulation, and impact on brain activity. He highlights the inseparable link between metabolic health, neuroplasticity, exercise, diet, and sleep.
Dr. Palmer explains the complex effects of stimulants on mitochondrial function. He notes that low doses of stimulants can improve brain metabolism by stimulating mitochondria and increasing dopamine, benefiting individuals with ADHD. However, he cautions that high doses can overstimulate mitochondria, leading to reactive oxygen species production, cellular damage, and chronic metabolic dysfunction.
Dr. Palmer discusses the historical presence of fasting in various cultures and healing rituals, suggesting that its persistence indicates meaningful health benefits. He mentions Valter Longo's fasting-mimicking diet, a plant-based, low-calorie diet (similar to a ketogenic diet), and highlights the research supporting its benefits. He notes that just not eating anything or eating 600 calories a day it can yield similar benefits, reducing the need for Valter Longo's proprietary product. Dr. Palmer also emphasizes the importance of funding diet studies to gain more robust scientific evidence.
Dr. Palmer explains the role of creatine in mitochondrial health and its potential benefits for neuropsychiatric disorders. He highlights that while creatine is foundational to energy transformation and mitochondrial function, research is limited due to lack of funding and its off-patent status.
Dr. Palmer discusses methylene blue as a mitochondrial agent and electron shuttle, explaining its potential role in reducing reactive oxygen species and oxidative stress. He cautions about the importance of dosage, highlighting the risk of reductive stress with overdose and serotonin syndrome. He notes limited but promising pilot trials in neuropsychiatric disorders.
Dr. Palmer discusses urolithin A as a supplement for improving muscle health and aging, citing well-designed studies that demonstrate its benefits for muscle mass and performance in elderly individuals. He reiterates that diet and exercise are crucial but that urolithin A may offer an additional advantage.
Dr. Palmer outlines the six pillars of lifestyle medicine: diet/nutrition, exercise/movement, sleep, substance use management, stress reduction practices, and relationships/purpose. He criticizes simplistic dietary advice and emphasizes the importance of exercise for increasing mitochondrial density and health. He also discusses the complex effects of stimulants and alcohol on mitochondrial function.
Dr. Palmer discusses the importance of mitochondrial health and the dangers of overstimulating metabolism. He uses the analogy of driving a car to explain how both under and overstimulation can be detrimental to mitochondrial function. He highlights the addictive nature of substances that quickly enhance metabolism and warns against depleting mitochondria through overstimulation, which can lead to the production of harmful reactive oxygen species. This clip provides a clear and actionable understanding of how to maintain healthy mitochondrial function.
The speakers discuss the challenges in changing American eating habits, drawing parallels to the fight against smoking. They highlight the role of marketing and industry influence in promoting unhealthy foods, referencing the American Heart Association's controversial lobbying against restrictions on junk food purchases with food stamp money. They suggest that appealing to a rebellious spirit and exposing manipulation by the food industry could be effective strategies for promoting healthier choices. The discussion touches on the need for top-down bans and the importance of incentivizing healthy behavior.
Dr. Palmer discusses the potential risks of serotonin syndrome associated with methylene blue use, especially in individuals already taking SSRIs. He explains that serotonin syndrome can often be mistaken for psychiatric symptoms, leading to misdiagnosis and inappropriate treatment.
Dr. Palmer explains a newly recognized autoimmune form of B12 deficiency that targets a protein (cd320) transporting B12 across the blood-brain barrier. He discusses the challenges in diagnosing this condition, as peripheral B12 levels may appear normal, necessitating a spinal tap for accurate assessment. He also notes that immune suppressive treatments and high-dose B12 injections may be potential solutions.
Huberman and Palmer discuss the contentious topic of vaccines and their potential impact on mitochondrial function and neurodevelopment, particularly in relation to autism. Palmer clarifies that inflammation can impair mitochondrial function and increase the risk of neurodevelopmental disorders. While acknowledging the existing research suggesting that vaccination does not increase the risk of autism, he notes the importance of considering individual variability in inflammatory responses and pre-existing vulnerabilities.
Dr. Palmer explains how adverse childhood experiences (ACEs) increase the risk for both mental and physical health issues. He highlights the link between trauma, metabolism, and mitochondrial function, noting that ACEs can shorten lifespan by 20 years.
Dr. Palmer highlights the importance of basic vitamins and minerals like B12, folate, and iron for mitochondrial function and mental health. He discusses the high prevalence of iron deficiency in young women and B12 deficiency in vegetarians/vegans, linking these deficiencies to neuropsychiatric disorders and emphasizing the need for awareness and supplementation.
Dr. Palmer explains the multifaceted role of mitochondria beyond just ATP production. He details their involvement in neurotransmitter synthesis, immune response regulation, hormone production (cortisol, estrogen, testosterone, progesterone), and epigenetics. He emphasizes that mitochondria are instrumental in the human stress response and act as a communication network within the body.
Dr. Palmer explains the diagnostic challenges in mental health, highlighting that labels like 'schizophrenia' often mask underlying causes such as B12 deficiency or autoimmune disorders. He advocates for a shift towards identifying and treating root causes rather than merely managing symptoms with medication, offering hope for more effective, personalized treatments and improved outcomes for individuals with severe mental illnesses.
Dr. Palmer explains how diseases of aging, such as obesity, type 2 diabetes, cardiovascular disease, cancer, and neurodegenerative disorders, are universally recognized, mental disorders are often overlooked in this category. He points out that depression, anxiety, and psychosis are also diseases of aging, supported by data showing increased antidepressant prescriptions in older populations. This challenges the common perception of mental disorders as primarily youth problems and highlights the need to consider metabolic health in addressing mental illness.
Dr. Palmer highlights the critical role of diet in metabolism and its consequences, citing the profound impact of breast milk on infant brain development. He emphasizes that maternal malnutrition during pregnancy increases the risk of metabolic and mental disorders in offspring. He strongly advises against ultra-processed foods, citing evidence of their detrimental effects on both physical and mental health. He points out the lack of adequate safety testing for food additives due to the 'generally regarded as safe' (GRAS) rule, and stresses the unequivocal link between ultra-processed food consumption and poor health outcomes.
Dr. Palmer discusses the ketogenic diet as a 100-year-old, evidence-based treatment for epilepsy, highlighting its effectiveness in stopping seizures even when medications fail. He cites controlled trials and Cochran reviews supporting its use in children with treatment-resistant epilepsy. He explains that the ketogenic diet mimics the fasting state, shifting metabolism and gene expression, resulting in life-changing effects. While not necessarily the healthiest diet for everyone, it serves as a powerful intervention with highly beneficial effects when done in a medically sound way.
Dr. Palmer emphasizes the importance of early intervention and comprehensive assessment for children showing signs of neurodevelopmental disorders. He suggests looking beyond the 'autism' label to identify underlying issues like nutrient deficiencies, autoimmune reactions, or metabolic dysfunction. He advocates for considering interventions such as ketogenic diets and addressing lifestyle factors to support overall health and mitochondrial function, highlighting the potential for AI to aid in solving the complex puzzle of neurodevelopmental disorders.
Dr. Palmer discusses the underfunding of nutritional research by the NIH and the influence of food industry lobbyists, particularly highlighting the American Heart Association's perceived bias. He emphasizes the importance of unbiased research to determine the true effects of ultra-processed foods on health and mitochondrial function.
Dr. Palmer and Andrew Huberman discuss the rising rates of autism and ADHD and the potential link to declining metabolic health in the population. They emphasize the importance of considering factors beyond genetics and vaccines, such as parental obesity, diabetes, and nutrient deficiencies, as significant contributors to neurodevelopmental disorders. They highlight that metabolic health, indicated by biomarkers like abdominal obesity, blood pressure, glucose levels, triglycerides, and HDL cholesterol, plays a critical role in offspring neurodevelopment, suggesting that improving metabolic health could be a key strategy for preventing and addressing these disorders.
Dr. Palmer discusses ongoing research efforts to develop blood biomarker tests for assessing mitochondrial dysfunction and predicting neurodevelopmental disorders like autism. He mentions a commercial company aiming to predict autism risk at age one, a leading mitochondrial researcher with a 20-biomarker set, and another group identifying five biomarkers to distinguish individuals with severe depression. While emphasizing that no single blood test exists for mitochondrial health, he highlights the potential of these research groups to create evidence-based tools for prospective parents to assess and improve their metabolic health, requiring significant NIH funding and a shift from the current research model.
Dr. Palmer and Andrew Huberman discuss how metabolic health extends beyond obesity and includes essential vitamins and nutrients necessary for mitochondrial function. They highlight the case of a thin, attractive 14-year-old girl who can be metabolically unhealthy due to iron deficiency, leading to anxiety, depression, or eating disorder symptoms. They emphasize that these mental health issues might be misdiagnosed and treated with medication (e.g., Prozac) when the underlying cause is a nutrient deficiency. They propose the creation of a metric for all-around metabolic health to incentivize better lifestyle choices and healthier offspring, potentially reducing the burden of incurable mental health disorders.